Log In
BCIQ
Print this Print this
 

heparin plus DNase

  Manage Alerts
Collapse Summary General Information
Company Ockham Biotech Ltd.
DescriptionInhaled heparin plus Dnase
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacromolecule: Polysaccharide
Latest Stage of DevelopmentPreclinical
Standard IndicationCystic fibrosis (CF)
Indication DetailsTreat cystic fibrosis (CF)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today